Bhavjot Bindra

1.5k total citations · 1 hit paper
10 papers, 1.1k citations indexed

About

Bhavjot Bindra is a scholar working on Hematology, Immunology and Transplantation. According to data from OpenAlex, Bhavjot Bindra has authored 10 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Hematology, 5 papers in Immunology and 2 papers in Transplantation. Recurrent topics in Bhavjot Bindra's work include Hematopoietic Stem Cell Transplantation (10 papers), Multiple Myeloma Research and Treatments (6 papers) and T-cell and B-cell Immunology (5 papers). Bhavjot Bindra is often cited by papers focused on Hematopoietic Stem Cell Transplantation (10 papers), Multiple Myeloma Research and Treatments (6 papers) and T-cell and B-cell Immunology (5 papers). Bhavjot Bindra collaborates with scholars based in United States and Israel. Bhavjot Bindra's co-authors include John Koreth, Philippe Armand, Robert J. Soiffer, Edwin P. Alyea, Jerome Ritz, Corey Cutler, Joseph H. Antin, Vincent T. Ho, Haesook T. Kim and Sean M. McDonough and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

Bhavjot Bindra

10 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Interleukin-2 and Regulatory T Cells in Graft-versus-Host Disease

2011 809 citations John Koreth, Ken‐ichi Matsuoka et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bhavjot Bindra United States	6	778	512	199	91	87	10	1.1k
Maria Bieniaszewska Poland	11	550 0.7×	261 0.5×	207 1.0×	107 1.2×	85 1.0×	34	877
Edward S. Morris Australia	15	691 0.9×	623 1.2×	190 1.0×	76 0.8×	54 0.6×	25	958
Jason Butler Australia	12	330 0.4×	595 1.2×	210 1.1×	83 0.9×	43 0.5×	43	900
Andrea Assanelli Italy	18	455 0.6×	416 0.8×	263 1.3×	107 1.2×	69 0.8×	47	1.2k
Masanao Teramura Japan	16	333 0.4×	565 1.1×	143 0.7×	74 0.8×	96 1.1×	43	872
Ying-Qiu Gu China	5	501 0.6×	811 1.6×	322 1.6×	81 0.9×	86 1.0×	11	1.0k
EC Guinan United States	7	551 0.7×	303 0.6×	231 1.2×	109 1.2×	78 0.9×	9	889
Y Morishita Japan	15	374 0.5×	511 1.0×	188 0.9×	83 0.9×	22 0.3×	34	869
Alexey Maschan Russia	17	231 0.3×	477 0.9×	236 1.2×	147 1.6×	84 1.0×	137	854
Édouard Forcade France	18	372 0.5×	674 1.3×	441 2.2×	138 1.5×	46 0.5×	105	1.2k

Countries citing papers authored by Bhavjot Bindra

Since Specialization

Citations

This map shows the geographic impact of Bhavjot Bindra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bhavjot Bindra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bhavjot Bindra more than expected).

Fields of papers citing papers by Bhavjot Bindra

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bhavjot Bindra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bhavjot Bindra. The network helps show where Bhavjot Bindra may publish in the future.

Co-authorship network of co-authors of Bhavjot Bindra

This figure shows the co-authorship network connecting the top 25 collaborators of Bhavjot Bindra. A scholar is included among the top collaborators of Bhavjot Bindra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bhavjot Bindra. Bhavjot Bindra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

1.

Koreth, John, Haesook T. Kim, Paulina Lange, et al.. (2015). A Bortezomib-Based Regimen Offers Promising Survival and Graft-versus-Host Disease Prophylaxis in Myeloablative HLA-Mismatched and Unrelated Donor Transplantation: A Phase II Trial. Biology of Blood and Marrow Transplantation. 21(11). 1907–1913. 23 indexed citations

2.

Herrera, Alex F., Haesook T. Kim, Bhavjot Bindra, et al.. (2014). A Phase II Study of Bortezomib Plus Prednisone for Initial Therapy of Chronic Graft-versus-Host Disease. Biology of Blood and Marrow Transplantation. 20(11). 1737–1743. 37 indexed citations

3.

Nikiforow, Sarah, Haesook T. Kim, Bhavjot Bindra, et al.. (2013). Phase I Study of Alemtuzumab for Therapy of Steroid-Refractory Chronic Graft-versus-Host Disease. Biology of Blood and Marrow Transplantation. 19(5). 804–811. 13 indexed citations

4.

Cutler, Corey, Haesook T. Kim, Bhavjot Bindra, et al.. (2013). Rituximab prophylaxis prevents corticosteroid-requiring chronic GVHD after allogeneic peripheral blood stem cell transplantation: results of a phase 2 trial. Blood. 122(8). 1510–1517. 89 indexed citations

5.

Koreth, John, Haesook T. Kim, Paulina Lange, et al.. (2013). A Bortezomib-Based Regimen Offers Excellent Outcomes In Myeloablative HLA-Mismatched and Unrelated Donor Transplantation: Phase II Results. Blood. 122(21). 3335–3335. 1 indexed citations

6.

Herrera, Alex F., Haesook T. Kim, Bhavjot Bindra, et al.. (2013). A Phase II Study Of Proteasome-Inhibition For Initial Therapy Of Chronic Graft-Versus-Host Disease. Blood. 122(21). 909–909. 1 indexed citations

7.

Koreth, John, Kristen E. Stevenson, Haesook T. Kim, et al.. (2012). Bortezomib-Based Graft-Versus-Host Disease Prophylaxis in HLA-Mismatched Unrelated Donor Transplantation. Journal of Clinical Oncology. 30(26). 3202–3208. 104 indexed citations

8.

Koreth, John, Ken‐ichi Matsuoka, Haesook T. Kim, et al.. (2011). Interleukin-2 and Regulatory T Cells in Graft-versus-Host Disease. New England Journal of Medicine. 365(22). 2055–2066. 809 indexed citations breakdown →

9.

Koreth, John, Kristen E. Stevenson, Bhavjot Bindra, et al.. (2011). A Prospective Phase I/II Trial of Bortezomib-Based Graft-Versus-Host-Disease Prophylaxis in HLA-Mismatched Unrelated Donor Reduced-Intensity Conditioning Hematopoietic Stem Cell Transplantation: Encouraging Safety, Efficacy, and Survival. Biology of Blood and Marrow Transplantation. 17(2). S165–S166. 1 indexed citations

10.

Cutler, Corey, Lixian Sun, Haesook Kim, et al.. (2010). Prophylactic Rituximab After Allogeneic Stem Cell Transplantation Prevents Steroid-Requiring Chronic Graft-Vs.Host Disease. Blood. 116(21). 214–214. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact